Destia
FranceWho owns Destia?
Destia is a French Healthcare company, currently owned by Turenne Groupe since 2026 and 2 other investors. It changed hands in 2026, when XAnge sold.
Hand-verified · updated 2026-04-21
Open JSON · CC-BY
Key facts
- ·Co-held by Azulis Capital, Siparex and Turenne Groupe since 2021.
- ·Average hold across 2 realized cycles: 5 years.
- ·5 distinct PE sponsors across ownership cycles.
Ownership history
5 ownership periods · co-invest detected
Societe Generale Capital Partenaires sold DESTIA to Siparex in 2021 after 5 years.
XAnge sold Destia to Bpifrance, Three Hills, Turenne Santé and Groupe VYV in 2026 after 5 years.
More Turenne Groupe portfolio companies
From the same investor, across funds.
More PE-backed in Healthcare
Comparable healthcare deals from other GPs.
US
Questions
Who owns Destia?
Destia is currently owned by Turenne Groupe, Siparex and 1 other, through Capital Sante 3, since 2026.
When did Turenne Groupe and 2 others acquire Destia?
Turenne Groupe and 2 others acquired Destia in 2026.
Who did Destia sell to?
XAnge sold Destia to Bpifrance, Three Hills, Turenne Santé and Groupe VYV in 2026 (Recapitalization). Societe Generale Capital Partenaires sold Destia to Siparex in 2021 (Secondary).
Who has owned Destia over time?
Destia has been through 5 private-equity ownership periods: Societe Generale Capital Partenaires · via SGCP Evergreen (balance sheet) · 2016–2021 · sold to Siparex · (Secondary); XAnge · via XAnge 04 · 2021–2026 · sold to Bpifrance, Three Hills, Turenne Santé and Groupe VYV · (Recapitalization); Azulis Capital · via Azulis MMF VI · since 2021; Siparex · via Siparex ETI 5 · since 2024; Turenne Groupe · via Capital Sante 3 · since 2026.